Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y3LL
|
||||
Former ID |
DIB009386
|
||||
Drug Name |
Taprenepag
|
||||
Synonyms |
Taprenepag isopropyl; CP-544326; PF-04217329; PF-4217329
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Pfizer Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H22N4O5S
|
||||
InChI |
InChI=1S/C24H22N4O5S/c29-24(30)18-33-22-5-1-4-20(14-22)17-27(34(31,32)23-6-2-11-25-15-23)16-19-7-9-21(10-8-19)28-13-3-12-26-28/h1-15H,16-18H2,(H,29,30)
|
||||
InChIKey |
MFFBXYNKZHTCEY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin E2receptor, EP2 subtype | Target Info | Agonist | [531603] | |
References | |||||
Ref 522182 | ClinicalTrials.gov (NCT00572455) Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.. U.S. National Institutes of Health. | ||||
Ref 541134 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5816). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.